Vermeulen A, Chadha D R
Eur J Clin Pharmacol. 1983;24(4):449-51. doi: 10.1007/BF00609884.
To compare the natriuretic and diuretic effects of a slow-release and a standard formulation of furosemide, 18 elderly patients with stable congestive heart failure were hospitalized and treated with one of these formulations in a double blind randomized trial. Patients received placebo on the first 2 days, furosemide on the third day and placebo again on the last 2 days of the study. In patients receiving the standard formulation mean urine output was increased only on the day of active treatment. However, in patients who had received the slow-release preparation, increased urine excretion was seen both on the day of active treatment and on the subsequent day. The total diuresis (0-48 h) in the 2 groups was equal, but a peak diuresis (0-6 h) was seen only in patients on the standard formulation of furosemide. Sodium excretion followed the pattern of urine excretion. Furosemide in a slow-release formulation offers advantages in maintenance therapy in congestive heart failure, especially in elderly patients.
为比较速尿缓释制剂和标准制剂的利钠及利尿作用,18例稳定型充血性心力衰竭老年患者住院并在一项双盲随机试验中接受其中一种制剂治疗。患者在研究的前2天接受安慰剂,第3天接受速尿,最后2天再次接受安慰剂。接受标准制剂的患者平均尿量仅在积极治疗当天增加。然而,接受缓释制剂的患者在积极治疗当天及随后一天均出现尿量增加。两组的总利尿量(0 - 48小时)相等,但仅速尿标准制剂组患者出现了利尿高峰(0 - 6小时)。钠排泄遵循尿排泄模式。速尿缓释制剂在充血性心力衰竭的维持治疗中具有优势,尤其是在老年患者中。